Patent · US Active

NRIP1 regulation of apolipoprotein A1

US8257921B1 · kind B1 · utility

6Cited by
0References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 22, 2009
Grant dateSep 4, 2012
Priority date
Expiry dateNov 23, 2030

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/775
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The present invention provides, in part, methods for identifying inhibitors of NRIP1 and methods of using such inhibitors. Methods of treating NRIP1-mediated disorders using NRIP1 inhibitor are also provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.